Enanta Pharmaceuticals, Inc. (ENTA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 17.16M | 18.61M | 15.13M | 18.31M | 14.93M | 16.96M | 14.61M | 17.97M | 17.05M | 18M | 18.93M | 18.89M | 17.8M | 23.59M | 20.32M | 19.48M | 18.72M | 27.65M | 23.57M | 21.62M |
| Revenue Growth % | 14.96% | 9.76% | 3.55% | 1.91% | -12.48% | -5.8% | -22.84% | -4.88% | -4.16% | -23.67% | -6.82% | -3.01% | -4.92% | -14.7% | -13.82% | -9.92% | -7.03% | -12.9% | -0.24% | 15.93% |
| Cost of Goods Sold | 1.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 540K | 511K | 655K | 716K | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 7.05% | - | - | - | - | - | - | - | - | - | - | - | 3.03% | 2.17% | 3.22% | 3.68% | - | - | - | - |
| Gross Profit | 15.95M | 18.61M | 15.13M | 18.31M | 14.93M | 16.96M | 14.61M | 17.97M | 17.05M | 18M | 18.93M | 18.89M | 17.25M | 23.07M | 19.66M | 18.76M | 18.72M | 27.65M | 23.57M | 21.62M |
| Gross Margin % | 92.95% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 96.97% | 97.83% | 96.78% | 96.32% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | 6.86% | 9.76% | 3.55% | 1.91% | -12.48% | -5.8% | -22.84% | -4.88% | -1.16% | -21.98% | -3.71% | 0.69% | -7.81% | -16.54% | -16.6% | -13.23% | -7.03% | -12.9% | -0.24% | 15.93% |
| Operating Expenses | 27.8M | 29.87M | 33.51M | 37.21M | 39.45M | 40.5M | 44.46M | 42.16M | 49.82M | 52.89M | 49.96M | 55.6M | 56.71M | 53.09M | 46.71M | 51.3M | 52.56M | 58.06M | 57.3M | 55.47M |
| OpEx % of Revenue | 162.03% | 160.45% | 221.56% | 203.16% | 264.32% | 238.82% | 304.38% | 234.58% | 292.13% | 293.78% | 263.9% | 294.33% | 318.66% | 225.09% | 229.91% | 263.38% | 280.85% | 209.99% | 243.06% | 256.53% |
| Selling, General & Admin | 9.57M | 9.01M | 9.7M | 10M | 11.39M | 12.85M | 13.68M | 13.41M | 14.23M | 16.52M | 13.79M | 12.62M | 13.24M | 12.19M | 11.91M | 12.21M | 10.48M | 9.51M | 8.36M | 8.48M |
| SG&A % of Revenue | 55.76% | 48.4% | 64.15% | 54.59% | 76.3% | 75.75% | 93.67% | 74.64% | 83.47% | 91.75% | 72.87% | 66.79% | 74.39% | 51.66% | 58.64% | 62.7% | 55.97% | 34.39% | 35.44% | 39.2% |
| Research & Development | 19.44M | 20.86M | 23.81M | 27.21M | 28.07M | 27.66M | 30.78M | 28.74M | 35.59M | 36.37M | 36.17M | 42.99M | 43.47M | 40.9M | 34.8M | 39.09M | 42.09M | 48.55M | 48.95M | 46.99M |
| R&D % of Revenue | 113.31% | 112.05% | 157.41% | 148.57% | 188.03% | 163.08% | 210.71% | 159.94% | 208.66% | 202.03% | 191.04% | 227.54% | 244.27% | 173.42% | 171.27% | 200.68% | 224.87% | 175.6% | 207.62% | 217.32% |
| Other Operating Expenses | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 258K | 0 | 0 |
| Operating Income | -11.85M | -11.25M | -18.39M | -18.89M | -24.53M | -23.54M | -29.85M | -24.18M | -32.77M | -34.89M | -31.03M | -36.71M | -39.45M | -30.01M | -27.05M | -32.54M | -33.85M | -30.41M | -33.73M | -33.85M |
| Operating Margin % | -69.07% | -60.45% | -121.56% | -103.16% | -164.32% | -138.82% | -204.38% | -134.58% | -192.13% | -193.78% | -163.9% | -194.33% | -221.7% | -127.25% | -133.13% | -167.05% | -180.85% | -109.99% | -143.06% | -156.53% |
| Operating Income Growth % | 51.68% | 52.2% | 38.41% | 21.88% | 25.14% | 32.51% | 3.79% | 34.12% | 16.95% | -16.24% | -14.72% | -12.82% | -16.56% | 1.3% | 19.8% | 3.86% | -13.96% | -147.25% | -70.48% | -48.11% |
| EBITDA | -10.64M | -10.02M | -17.1M | -17.68M | -23.32M | -22.65M | -29.38M | -23.59M | -32.15M | -34.24M | -30.36M | -36.06M | -38.91M | -29.5M | -26.39M | -31.82M | -33.02M | -29.63M | -32.92M | -33.02M |
| EBITDA Margin % | -62.03% | -53.84% | -113.07% | -96.55% | -156.26% | -133.58% | -201.1% | -131.27% | -188.49% | -190.21% | -160.37% | -190.88% | -218.66% | -125.09% | -129.91% | -163.38% | -176.45% | -107.17% | -139.64% | -152.72% |
| EBITDA Growth % | 54.37% | 55.76% | 41.78% | 25.04% | 27.44% | 33.85% | 3.25% | 34.58% | 17.39% | -16.07% | -15.03% | -13.32% | -17.82% | 0.43% | 19.83% | 3.63% | -14.41% | -159.27% | -74.43% | -50.55% |
| D&A (Non-Cash Add-back) | 1.21M | 1.23M | 1.28M | 1.21M | 1.2M | 889K | 479K | 594K | 621K | 642K | 669K | 651K | 540K | 511K | 655K | 716K | 822K | 780K | 806K | 823K |
| EBIT | -11.85M | -8.83M | -16.28M | -16.61M | -22.23M | -20.74M | -26.61M | -20.7M | -28.96M | -30.59M | -26.37M | -32.85M | -37.61M | -29.02M | -26.33M | -32.15M | -33.85M | -30.41M | -33.73M | -33.85M |
| Net Interest Income | -1.23M | -661K | -282K | 667K | 578K | 837K | 595K | 1.13M | 1.25M | 857K | 1.51M | 1.87M | 1.84M | 993K | 631K | 393K | 255K | 258K | 360K | 439K |
| Interest Income | 2.08M | 2.42M | 2.1M | 2.29M | 2.29M | 2.8M | 3.18M | 3.49M | 3.81M | 4.3M | 4.66M | 3.87M | 1.84M | 993K | 631K | 393K | 255K | 258K | 360K | 439K |
| Interest Expense | 3.32M | 3.08M | 2.39M | 1.62M | 1.71M | 1.96M | 2.58M | 2.35M | 2.56M | 3.44M | 3.15M | 2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -1.23M | -661K | -282K | 667K | 578K | 837K | 668K | 1.13M | 1.25M | 857K | 1.51M | 1.87M | 1.84M | 993K | 714K | 393K | 255K | 258K | 333K | 439K |
| Pretax Income | -13.08M | -11.91M | -18.67M | -18.23M | -23.95M | -22.71M | -29.19M | -23.05M | -31.52M | -34.03M | -29.52M | -34.84M | -37.61M | -29.02M | -26.33M | -32.15M | -33.59M | -30.15M | -33.39M | -33.41M |
| Pretax Margin % | -76.25% | -64% | -123.42% | -99.52% | -160.45% | -133.89% | -199.81% | -128.28% | -184.82% | -189.02% | -155.91% | -184.44% | -211.37% | -123.04% | -129.62% | -165.03% | -179.48% | -109.05% | -141.65% | -154.5% |
| Income Tax | 7K | 24K | 32K | 29K | -1.3M | -416K | -363K | -395K | -363K | -622K | -1.41M | 4.22M | 44K | -34K | 14K | -447K | 0 | -36K | -8.79M | -9.38M |
| Effective Tax Rate % | -0.05% | -0.2% | -0.17% | -0.16% | 5.45% | 1.83% | 1.24% | 1.71% | 1.15% | 1.83% | 4.78% | -12.11% | -0.12% | 0.12% | -0.05% | 1.39% | 0% | 0.12% | 26.34% | 28.09% |
| Net Income | -13.09M | -11.94M | -18.7M | -18.25M | -22.64M | -22.29M | -28.82M | -22.66M | -31.16M | -33.41M | -28.11M | -39.06M | -37.66M | -28.99M | -26.35M | -31.7M | -33.59M | -30.11M | -24.6M | -24.02M |
| Net Margin % | -76.29% | -64.13% | -123.64% | -99.68% | -151.71% | -131.43% | -197.32% | -126.08% | -182.7% | -185.56% | -148.46% | -206.78% | -211.62% | -122.9% | -129.68% | -162.74% | -179.48% | -108.92% | -104.34% | -111.1% |
| Net Income Growth % | 42.19% | 46.44% | 35.12% | 19.43% | 27.32% | 33.28% | -2.55% | 42% | 17.26% | -15.25% | -6.68% | -23.23% | -12.1% | 3.75% | -7.11% | -31.95% | -52.38% | -261.61% | 16.16% | -68.41% |
| Net Income (Continuing) | -13.09M | -11.94M | -18.7M | -18.25M | -22.64M | -22.29M | -28.82M | -22.66M | -31.16M | -33.41M | -28.11M | -39.06M | -37.66M | -28.99M | -26.35M | -31.7M | -33.59M | -30.11M | -24.6M | -24.02M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.45 | -0.56 | -0.87 | -0.86 | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 | -1.33 | -1.86 | -1.79 | -1.39 | -1.28 | -1.53 | -1.63 | -1.48 | -1.22 | -1.19 |
| EPS Growth % | 57.55% | 46.67% | 36.03% | 19.63% | 27.89% | 33.54% | -2.26% | 42.47% | 17.88% | -13.67% | -3.91% | -21.57% | -9.82% | 6.08% | -4.92% | -28.57% | -49.54% | -260.98% | 16.44% | -67.61% |
| EPS (Basic) | -0.45 | -0.56 | -0.87 | -0.86 | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 | -1.33 | -1.86 | -1.79 | -1.39 | -1.28 | -1.53 | -1.63 | -1.48 | -1.22 | -1.19 |
| Diluted Shares Outstanding | 28.89M | 21.38M | 21.38M | 21.32M | 21.36M | 21.24M | 21.19M | 21.18M | 21.17M | 21.09M | 21.06M | 21.05M | 21.04M | 20.82M | 20.6M | 20.71M | 20.55M | 20.39M | 20.22M | 20.2M |
| Basic Shares Outstanding | 28.89M | 21.38M | 21.38M | 21.32M | 21.36M | 21.24M | 21.19M | 21.18M | 21.17M | 21.09M | 21.06M | 21.05M | 21.04M | 20.82M | 20.6M | 20.71M | 20.55M | 20.39M | 20.18M | 20.19M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |